Literature DB >> 28752480

Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein.

Julie Petermann1, Romain Bonnefond2, Isabelle Mermoud3, Dewi Rantoen3, Laure Meynard3, Christopher Munro4, Linda H L Lua4, Thomas Hüe5.   

Abstract

Cattle tick infestations remain an important burden for farmers in tropical area like in New Caledonia. With the development of acaricide resistance, tick vaccines should be an attractive alternative to control ticks but their efficacy needs to be improved. In this study three adjuvants were studied in an experimental tick vaccine with a Bm86 protein to assess their performance in terms of antibody productions and adverse reactions following vaccinations. The water-in-oil adjuvant ISA 61 VG led to higher antibody titers compared to a water-in-oil-in-water adjuvant ISA 201 VG and an aqueous polymeric adjuvant Montanide Gel 01. Vaccinations with these three adjuvants did not produce severe general reaction but an increase in skin thickness was observed especially with both oil-based emulsions. These results indicated that the water-in-oil adjuvant is the most interesting to use for this vaccine but local adverse reactions remain an issue.

Entities:  

Keywords:  Adjuvant; Integrated management; Rhipicephalus australis; Side reaction; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28752480     DOI: 10.1007/s10493-017-0156-4

Source DB:  PubMed          Journal:  Exp Appl Acarol        ISSN: 0168-8162            Impact factor:   2.132


  15 in total

Review 1.  Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac.

Authors:  J de la Fuente; M Rodríguez; C Montero; M Redondo; J C García-García; L Méndez; E Serrano; M Valdés; A Enríquez; M Canales; E Ramos; O Boué; H Machado; R Lleonart
Journal:  Genet Anal       Date:  1999-11

2.  Inflammatory response to clostridial vaccines in feedlot cattle.

Authors:  G L Stokka; A J Edwards; M F Spire; R T Brandt; J E Smith
Journal:  J Am Vet Med Assoc       Date:  1994-02-01       Impact factor: 1.936

3.  Evaluation of three 'ready to formulate' oil adjuvants for foot-and-mouth disease vaccine production.

Authors:  A V Iyer; S Ghosh; S N Singh; R A Deshmukh
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

4.  Evaluation of tickGARD(PLUS), a novel vaccine against Boophilus microplus, in lactating Holstein-Friesian cows.

Authors:  N N Jonsson; A L Matschoss; P Pepper; P E Green; M S Albrecht; J Hungerford; J Ansell
Journal:  Vet Parasitol       Date:  2000-03-01       Impact factor: 2.738

Review 5.  Vaccination against Boophilus microplus: localization of antigens on tick gut cells and their interaction with the host immune system.

Authors:  D H Kemp; R D Pearson; J M Gough; P Willadsen
Journal:  Exp Appl Acarol       Date:  1989-06       Impact factor: 2.132

6.  Bm86 midgut protein sequence variation in South Texas cattle fever ticks.

Authors:  Jeanne M Freeman; Ronald B Davey; Lowell S Kappmeyer; Diane M Kammlah; Pia U Olafson
Journal:  Parasit Vectors       Date:  2010-11-03       Impact factor: 3.876

7.  Bovine immunoprotection against Rhipicephalus (Boophilus) microplus with recombinant Bm86-Campo Grande antigen.

Authors:  Rodrigo Casquero Cunha; Adalberto Angel Pérez de León; Fábio Pereira Leivas Leite; Luciano da Silva Pinto; Alceu Gonçalves Dos Santos Júnior; Renato Andreotti
Journal:  Rev Bras Parasitol Vet       Date:  2012 Jul-Sep

Review 8.  Adjuvants in veterinary vaccines: modes of action and adverse effects.

Authors:  Anna R Spickler; James A Roth
Journal:  J Vet Intern Med       Date:  2003 May-Jun       Impact factor: 3.333

9.  Commercialisation of a recombinant vaccine against Boophilus microplus.

Authors:  P Willadsen; P Bird; G S Cobon; J Hungerford
Journal:  Parasitology       Date:  1995       Impact factor: 3.234

10.  A versatile ligation-independent cloning method suitable for high-throughput expression screening applications.

Authors:  Nick S Berrow; David Alderton; Sarah Sainsbury; Joanne Nettleship; Rene Assenberg; Nahid Rahman; David I Stuart; Raymond J Owens
Journal:  Nucleic Acids Res       Date:  2007-02-22       Impact factor: 16.971

View more
  6 in total

1.  Experimental efficacy of a vaccine against Rhipicephalus australis.

Authors:  Thomas Hüe; Julie Petermann; Romain Bonnefond; Isabelle Mermoud; Dewi Rantoen; Tony Vuocolo
Journal:  Exp Appl Acarol       Date:  2017-11-06       Impact factor: 2.132

Review 2.  Metazoan Parasite Vaccines: Present Status and Future Prospects.

Authors:  Christian Stutzer; Sabine A Richards; Mariette Ferreira; Samantha Baron; Christine Maritz-Olivier
Journal:  Front Cell Infect Microbiol       Date:  2018-03-13       Impact factor: 5.293

3.  Inactivated alpha toxin from Clostridium novyi type B in nano-emulsion protect partially protects Swiss mice from lethal alpha toxin challenge.

Authors:  Mellanie Karoline C Felix; Tullio T Deusdará; Lucas Samuel S Santos; Raimundo Wagner S Aguiar; Roberto Franco T Corrêa; Igor V Brandi; Eliane M Sobrinho; Bergmann M Ribeiro; Luis André M Mariúba; Paulo A Nogueira; Kattyanne S Costa; Kelvinson F Viana; Alex Sander R Cangussu
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

4.  Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae.

Authors:  Li-Jun Guan; Shi-Xuan Pei; Ji-Jian Song; Peng-Fei Zhan; Yi-Nong Han; Yun Xue; Ke Ding; Zhan-Qin Zhao
Journal:  Front Vet Sci       Date:  2022-07-26

5.  Molecular characterization of the recombinant protein RmLTI-BmCG-LTB: Protective immunity against Rhipicephalus (Boophilus) microplus.

Authors:  Bárbara Guimarães Csordas; Rodrigo Casquero Cunha; Marcos Valério Garcia; Sérgio Silva da Silva; Fábio Leivas Leite; Renato Andreotti
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

6.  Sunflower seed oil containing ginseng stem-leaf saponins (E515-D) is a safe adjuvant for Newcastle disease vaccine.

Authors:  L Yuan; Y Wang; Z Li; X Ma; X Cui; X Chi; W Xu; S Hu
Journal:  Poult Sci       Date:  2020-07-24       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.